Rebif Pregnancy Registry.

Trial Profile

Rebif Pregnancy Registry.

Phase of Trial: Phase IV

Latest Information Update: 23 Aug 2011

At a glance

  • Drugs Interferon beta-1b (Primary)
  • Indications Multiple sclerosis
  • Focus Adverse reactions
  • Sponsors EMD Serono; Serono SA
  • Most Recent Events

    • 01 Jun 2010 Actual end date changed from 1 Apr 2008 to 1 Feb 2008 as reported by
    • 01 Jun 2010 Additional lead trial investigator (Dan Mikol, MD) identified as reported by
    • 01 Jun 2010 Actual number of patients changed from 300 to 36 as reported by
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top